Last updated Nov 3, 2026
A 3-year-old with progressive cerebellar ataxia is noted to have oculocutaneous telangiectasias. He has had recurrent sinopulmonary infections. Labs show elevated AFP, low IgA, and lymphopenia. A chest CT is avoided due to radiation sensitivity.
AR; ATM, encoding a serine/threonine kinase that double-strand DNA breaks activate to signal DNA repair, cell cycle checkpoints, and apoptosis. Biallelic loss-of-function variants; residual kinase activity gives the milder variant form.
- ATM heterozygous carriers: increased breast cancer risk (~2x; ATM is a moderate-penetrance breast cancer gene)
The ATM protein is a serine/threonine kinase of the phosphoinositide 3-kinase family. Double-strand DNA breaks activate it, and it phosphorylates many proteins involved in DNA repair, cell cycle checkpoints, and apoptosis; it also acts in RNA metabolism and transcription regulation that affect redox and calcium balance. Its absence disrupts pathways in the nucleus, cytoplasm, mitochondria, and peroxisomes, which is why many organs are affected, the cerebellum most prominently in the nervous system.
The mechanism is loss of function, and residual kinase activity sets severity:
- Classic A-T: no kinase activity. Nonsense, frameshift, start codon, and splice site variants and out-of-frame deletions mostly trigger nonsense-mediated decay, so no protein is made.
- Variant A-T: residual kinase activity, mainly from missense variants or splice variants that still let some transcript splice normally. The course is milder and immune function is generally normal.
The DNA repair defect underlies the cancer risk: about 25% in classic A-T (median age at diagnosis 12.5 years) and 29.5% in variant A-T. Affected individuals are also radiosensitive, which is why ionizing radiation and radiotherapy are contraindicated. For a variant of uncertain significance, immunoblot for the protein or a kinase assay is recommended.
Neurological:
- Progressive cerebellar ataxia (onset age 1-4 years, wheelchair-bound by adolescence)
- Oculomotor apraxia
- Dysarthria, choreoathetosis
Telangiectasias:
- Conjunctival and cutaneous (appear age 3-6 years)
Immunodeficiency:
- Variable T and B cell deficiency
- Low IgA, IgG subclass deficiency
- Recurrent sinopulmonary infections
Cancer predisposition:
- Lymphoma and leukemia (especially in childhood)
- Increased risk of solid tumors in adulthood
- Radiation sensitivity: avoid unnecessary X-rays and CT scans
Lab findings:
- Elevated serum AFP (~95%)
- Elevated chromosomal breakage (diagnostic test)
- Elevated serum AFP (present in ~95%) plus low or absent IgA and IgG subclasses supports the diagnosis in a child with ataxia and telangiectasias
- Radiosensitivity assays and increased chromosomal breakage (including translocations involving chromosomes 7 and 14) on irradiated lymphocytes
- Absent or reduced ATM protein on immunoblot; ATM sequence and deletion/duplication analysis confirms the diagnosis and enables carrier and prenatal testing
- Avoid ionizing radiation (X-rays, CT scans)
- Immunoglobulin replacement for severe immunodeficiency
- Aggressive treatment of pulmonary infections
- Cancer surveillance
- Physical and occupational therapy for ataxia
- No curative treatment; median survival ~25 years
The name of the disease is very helpful here:
- Patients present with ataxia (loss of balance) and telangiectasias (vessels on different surfaces of the body)
- The gene involved is ATM = Ataxia Telangiectasia, Mutated.